Yttrium-90 selective internal radiation therapy on liver cancer: the past, the present, and the future

Saved in:
Bibliographic Details
Title: Yttrium-90 selective internal radiation therapy on liver cancer: the past, the present, and the future
Authors: Jingqin MA, Linhong ZHANG, Minjie YANG, Jiabin CAI, Ying FANG, Rong LIU, Xudong QU, Lingxiao LIU, Zhiping YAN
Source: Zhongguo Linchuang Yixue, Vol 32, Iss 1, Pp 3-8 (2025)
Publisher Information: Shanghai Chinese Clinical Medicine Press Co., Ltd., 2025.
Publication Year: 2025
Collection: LCC:Medicine
Subject Terms: yttrium-90, selective internal radiation therapy, liver cancer, Medicine
Description: Yttrium-90 selective internal radiation therapy (90Y-SIRT) is a treatment technique that delivers radioactive microspheres precisely to the arterial vascular bed of neoplasms, utilizing beta radiation to administer a high local dose of radiation to the neoplasm tissues. This technology has demonstrated significant efficacy in patients with unresectable pirmary liver cancers and liver metastases. This article systematically reviews the development history and clinical application status of 90Y-SIRT in the treatment of liver cancer, and looks forward to future development directions.
Document Type: article
File Description: electronic resource
Language: English
Chinese
ISSN: 1008-6358
Relation: https://doaj.org/toc/1008-6358
DOI: 10.12025/j.issn.1008-6358.2025.20250142
Access URL: https://doaj.org/article/5b5bc42ca64949e2b7463ebe81d16333
Accession Number: edsdoj.5b5bc42ca64949e2b7463ebe81d16333
Database: Directory of Open Access Journals
Description
Abstract:Yttrium-90 selective internal radiation therapy (90Y-SIRT) is a treatment technique that delivers radioactive microspheres precisely to the arterial vascular bed of neoplasms, utilizing beta radiation to administer a high local dose of radiation to the neoplasm tissues. This technology has demonstrated significant efficacy in patients with unresectable pirmary liver cancers and liver metastases. This article systematically reviews the development history and clinical application status of 90Y-SIRT in the treatment of liver cancer, and looks forward to future development directions.
ISSN:10086358
DOI:10.12025/j.issn.1008-6358.2025.20250142